Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Acer, Ardelyx, Beigene, Ceruvia, Eli Lilly, Eyepoint, Innovent, Medsenic, Midatech, Nuvectis, Ocumension, Phanes, Regulus, Relief, Tranquis, Xenon.